Monday, September 28, 2020 7:31:08 AM
Capital from GEM helped RLF do what it needed to do to get up on QB and I just believe that now they have cash in the coffers to roll this thing out with NeuroRX and bring us up to the Nasdaq. I don’t care that the OS went from 2.3billion to 2.8billion. If GEM wants to part with shares at .60 then that’s fine and IMO those will be absorbed quickly. Sensibly I would think GEM would like to see the SP gain traction, get over $1.00 and up-list before letting go of many. They are the largest holder and have been putting in lots of cash. Also the press states that they don’t need anymore cash beyond this to complete trials & scale RLF so I view that as a very good thing. Let’s see them stick to it.
Don’t get me wrong, I am not normally a fan of convertible deals / warrant issuance in general but these Biotechs are kinda in a different realm IMO because they can get bought out SO FAST..... I have gotten impatient before and missed the big ride on these.... I’m strapped in. Lol.
GLTYA $RLFTF
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM